N-acetyl-L-cysteine
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 26 trials | ||||||
| Phase 2 | NCT06518044 | Jul → Dec 2024 overdue | aplastic anemia | Peking University People's Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06024031 | Sep 2023 → Sep 2024 overdue | acute myeloid leukemia | Peking University People's Hospital | Active not recruiting | No outcome recorded |
| Phase 2 | NCT05126004 | Dec 2021 → Jun 2024 | disease related to hematopoietic stem cell transplant, primary thrombocytopenia | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
| Phase 2 | NCT03982537 | Jun 2020 | head and neck cancer | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 2 | NCT03236220 | Aug 2017 → Jul 2018 | disease related to hematopoietic stem cell transplant | Peking University People's Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01840345 | Jan 2014 → Mar 2017 | neuropathy, painful | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03391856 | Mar → Dec 2018 | disease related to hematopoietic stem cell transplant, thrombocytopenia | Peking University People's Hospital | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03967665 | Oct 2018 → Sep 2021 | disease related to hematopoietic stem cell transplant | Peking University People's Hospital | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01241513 | Nov 2010 → May 2011 | altitude sickness | United States Army Research Institute of Environmental Medicine | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07662525 | Jun 2026 → Dec 2027 expected | autoimmune thrombocytopenic purpura | Peking University People's Hospital | Not yet recruiting | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 4 | NCT03589495 Comparator | Jul 2015 → Oct 2016 | — | Ain Shams University | Completed | No outcome recorded |
| — | NCT02718079 Background | Dec 2016 → Oct 2018 | acute liver failure | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT02999958 Comparator | Dec 2016 → May 2018 | — | Vitrolife | Completed | No outcome recorded |
| — | NCT02971878 Comparator | Nov 2016 → Feb 2018 | — | Fertilitetscentrum AB | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-acetyl-L-cysteine | “This is a prospective, single-arm trial designed to investigate whether atorvastatin combined with N-acetyl-L-cysteine (NAC) plus romiplostim can induce a sustained response...” NCT07662525 ↗14“This study will test whether treatment with N-acetyl-L-cysteine (NAC) is safe and decreases pain in patients with chronic neuropathic pain.” NCT01840345 ↗ “N-acetyl-L-cysteine (NAC)” NCT02999958 ↗ “N-acetyl-L-Cysteine” NCT01241513 ↗ |
| Known as | n acetyl cysteine | “100 mg/kg n acetyl cysteine dissolved in dextrose5%” NCT03589495 ↗1“N-acetylcysteine (NAC) as an antioxidant and” PMID 31381364 ↗ Aug 2019 |
| Known as | N-acetyl-L-cysteine (NAC) | “N-acetyl-L-cysteine (NAC)” NCT02999958 ↗ |
| Known as | NAC | “This is a prospective, single-arm trial designed to investigate whether atorvastatin combined with N-acetyl-L-cysteine (NAC) plus romiplostim can induce a sustained response...” NCT07662525 ↗5“Human embryos will be cultured in media that contains 3 antioxidants (Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC) and α-lipoic acid (ALA)) that can be found in the in...” NCT02971878 ↗ “further improved with N-acetyl-L-cysteine (NAC) treatment.” PMID 40403956 ↗ May 2025 “N-acetylcysteine (NAC) as an antioxidant and” PMID 31381364 ↗ Aug 2019 “N-acetyl-L-cysteine (NAC)” NCT03391856 ↗ “Drug: NAC” NCT01241513 ↗ |
| Route | Oral | “FDA-approved oral suspension form” NCT01241513 ↗ |